New Delhi : Aurobindo Pharma is all set to acquire troubled US-based nutritional supplement maker, Natrol Inc for USD 132.5 million (over Rs 810 crore) after emerging as the highest bidder for acquisition, reports PTI.
Aurobindo Pharma USA Inc, a subsidiary of the Hyderabad-based firm, has emerged as the highest bidder for acquisition of Natrol Inc and other affiliate entities, under a process to be finally approved by the United States Bankruptcy Court for the District of Delaware. The buyout of Natrol would provide the right platform for creating a fully-integrated OTC platform in the US and other international markets, it added.
Natrol, which manufactures and sells nutritional supplements in US and other international markets, provides Aurobindo with strong brand reputation and presence in a variety of attractive supplement markets, it said.
Aurobindo Pharma said the acquisition is subject to final approval by the US court and other statutory approvals.